Sunday , March 29 2020

Samsung Bioepis has applied for SB8 USA

Panoramic view of the Samsung Bioepis office building. Samsung Bioepis has begun reviewing documents for the SB8 (Avastin Biosimilar, ingredient name Bevacizumab) in the Food and Drug Administration (FDA). He said 20 …

Read More »

Here are the best offers [Updated]

<div _ngcontent-c17 = "" innerhtml = " This story was written in collaboration with Forbes' finds. Forbes Finds includes products that we think you'll love. Featured products are independently selected and combined …

Read More »